Semaglutide reduces blood glucose in a glucose dependent manner by stimulating insulin secretion and lowering glucagon secretion when blood glucose is high. The mechanism of blood glucose lowering also involves a minor delay in gastric emptying in the early postprandial phase.
FITARO 0.25MG INJECTION
$28.00
| Form | Injection |
| Packaging Type | Vial |
| Composition | Semaglutide |
| Brand | FITARO 0.25 INJECTION |
| Manufacturer | Incepta pharma |
| Usage / Application | Clinical |
